Ramirez-Hidalgo Maria, Trujillano-Cabello Javier, Espluges-Vidal Adrià, Reñé-Reñé Mercé, Santín Miguel, Sánchez-Montalvá Adrián, Bernet-Sánchez Albert, Gros-Navés Laura, Falguera Miquel
Nosocomial Infections Department, Arnau de Vilanova University Hospital, Lleida, Spain.
Universitat de Lleida, Lleida, Spain.
J Clin Tuberc Other Mycobact Dis. 2023 Mar 16;31:100361. doi: 10.1016/j.jctube.2023.100361. eCollection 2023 May.
Patients with pulmonary tuberculosis (PTB) disease and positive sputum cultures are the main source of infection. Culture conversion time is inconsistent and defining the length of respiratory isolation is challenging. The objective of this study is to develop a score to predict the length of isolation period.
A retrospective study was carried out to evaluated risk factors associated with persistent positive sputum cultures after 4 weeks of treatment in 229 patients with PTB. A multivariable logistic regression model was used to determinate predictors for positive culture and a scoring system was created based on the coefficients of the final model.
Sputum culture was persistently positive in 40.6%. Fever at consultation (1.87, 95% CI:1.02-3.41), smoking (2.44, 95% CI:1.36-4.37), >2 affected lung lobes (1.95, 95% CI:1.08-3.54), and neutrophil-to-lymphocyte ratio > 3.5 (2.22, 95% CI:1.24-3.99), were significantly associated with delayed culture conversion. Therefore, we assembled a severity score that achieved an area under the curve of 0.71 (95% CI:0.64-0.78).
In patients with smear positive PTB, a score with clinical, radiological and analytical parameters can be used as a supplemental tool to assist clinical decisions in isolation period.
肺结核(PTB)疾病且痰培养呈阳性的患者是主要感染源。培养转阴时间不一致,确定呼吸道隔离的时长具有挑战性。本研究的目的是开发一种评分系统来预测隔离期的长度。
开展一项回顾性研究,评估229例PTB患者治疗4周后痰培养持续阳性的相关危险因素。使用多变量逻辑回归模型确定培养阳性的预测因素,并基于最终模型的系数创建一个评分系统。
40.6%的患者痰培养持续呈阳性。就诊时发热(1.87,95%置信区间:1.02 - 3.41)、吸烟(2.44,95%置信区间:1.36 - 4.37)、超过2个肺叶受累(1.95,95%置信区间:1.08 - 3.54)以及中性粒细胞与淋巴细胞比值>3.5(2.22,95%置信区间:1.24 - 3.99)与培养转阴延迟显著相关。因此,我们构建了一个严重程度评分系统,其曲线下面积为0.71(95%置信区间:0.64 - 0.78)。
在涂片阳性的PTB患者中,一个包含临床、放射学和分析参数的评分可作为辅助隔离期临床决策的补充工具。